compound semaglutide risks of Compounding Evaluating Risk When Prescribing Compounded

Step 2 - Provider Consultation: You meet with an Ivm Health provider via video or chat

At Ro, were working to take the stress and guesswork out of the process

The FDA has expressed concerns about compounded versions, noting they "received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products." However, many patients used compounded versions successfully under proper medical supervision.

A structured, clinician-guided taper when you reach your goal

The all-in-one solution to healthy living and lower costs

Specifically, the FDA considered claims that compounded products are generic versions or contain the same active ingredient as FDA-approved GLP-1 drugs are false or misleading